Could Metabolic Syndrome Be a Predictor of Survival Outcomes in Upper Tract Urothelial Carcinoma? A Propensity Score Matching Study in a Large Chinese Center.

Dai, Xiang; Wang, Fei; Du, Yiqing; Qin, Caipeng; Lai, Shicong; Song, Yuxuan; Huang, Zixiong; Han, Songchen; Zhang, Xiaopeng; Xu, Tao

Dai, Xiang; Wang, Fei; Du, Yiqing; Qin, Caipeng; Lai, Shicong; Song, Yuxuan; Huang, Zixiong; Han, Songchen; Zhang, Xiaopeng; Xu, Tao.

Afiliación

Dai X; Department of Urology, Peking University People's Hospital, Beijing, China.
Wang F; Department of Urology, Peking University People's Hospital, Beijing, China.
Du Y; Department of Urology, Peking University People's Hospital, Beijing, China.
Qin C; Department of Urology, Peking University People's Hospital, Beijing, China.
Lai S; Department of Urology, Peking University People's Hospital, Beijing, China.
Song Y; Department of Urology, Peking University People's Hospital, Beijing, China.
Huang Z; Department of Urology, Peking University People's Hospital, Beijing, China.
Han S; Department of Urology, Peking University People's Hospital, Beijing, China.
Zhang X; Department of Urology, Peking University People's Hospital, Beijing, China.
Xu T; Department of Urology, Peking University People's Hospital, Beijing, China.

Front Oncol ; 12: 816915, 2022.

Article en En | MEDLINE | ID: mdl-35719953

Palabras clave

metabolic syndrome; prognosis; propensity score matching; survival; upper tract urothelial carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google